Cargando…
Conversion Ratio between Botox(®), Dysport(®), and Xeomin(®) in Clinical Practice
Botulinum neurotoxin has revolutionized the treatment of spasticity and is now administered worldwide. There are currently three leading botulinum neurotoxin type A products available in the Western Hemisphere: onabotulinum toxin-A (ONA) Botox(®), abobotulinum toxin-A (ABO), Dysport(®), and incobotu...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810210/ https://www.ncbi.nlm.nih.gov/pubmed/26959061 http://dx.doi.org/10.3390/toxins8030065 |